Hepatic insulin resistance is a common feature of NAFLD, even in non-obese patients.28 As such, we next evaluated protein levels of insulin signaling mediators in the liver of mice challenged with the FF model. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.